Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
agalsidase alfa (Replagal) (1 trial)
Fabry Disease (Phase 2)
Trials (1 total)
Trial APIs (1 total)